欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0229/003
药品名称Symbicort
活性成分
    • budesonide 160.0 µg/dose
    • formoterol fumarate 4.5 µg/dose
剂型Pressurised inhalation, suspension
上市许可持有人AstraZeneca AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Symbicort 160 mikrogrami/4,5 mikrogrami/izsmidzinājumā, aerosols inhalācijām, zem spiediena, suspensija
    • Lithuania (LT)
      Symbicort Turbuhaler 160 µg/4,5 µg/išpurškime suslėgtoji įkvepiamoji suspensija
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
      Symbicort
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
      Symbicort 160 micrograme/4,5 micrograme/inhalație suspensie de inhalat presurizată
    • Slovakia (SK)
    • Slovenia (SI)
    • Malta (MT)
    • Croatia (HR)
许可日期2016/03/03
最近更新日期2024/04/19
药物ATC编码
    • R03AK07 formoterol and budesonide
申请类型
  • TypeLevel1:Line Extension
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase